Envestnet Asset Management Inc. boosted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 5.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 60,880 shares of the biotechnology company’s stock after buying an additional 2,889 shares during the quarter. Envestnet Asset […] - 2025-04-15 08:14:52
Cerity Partners LLC grew its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 30.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,588 shares of the biotechnology company’s stock after purchasing an additional 2,702 shares during the quarter. Cerity […] - 2025-04-14 10:32:44
Federated Hermes Inc. lifted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 4.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,078 shares of the biotechnology company’s stock after buying an additional 305 shares during the quarter. Federated Hermes […] - 2025-04-14 09:54:56
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) EVP Paul A. Mahon sold 11,000 shares of the stock in a transaction on Thursday, April 3rd. The shares were sold at an average price of $306.18, for a total value of $3,367,980.00. Following the sale, the executive vice president now owns 36,781 shares in the company, […] - 2025-04-10 08:12:55
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) Director Raymond Dwek sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, April 7th. The shares were sold at an average price of $284.55, for a total value of $1,138,200.00. Following the completion of the transaction, the director now owns 1,750 shares […] - 2025-04-10 08:12:54
Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the twelve ratings firms that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have given a […] - 2025-04-09 06:08:53
Korea Investment CORP grew its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 6.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 39,289 shares of the biotechnology company’s stock after buying an additional 2,300 shares during the quarter. Korea Investment CORP’s holdings in United Therapeutics were worth $13,863,000 at the […] - 2025-03-31 10:40:53
Envestnet Portfolio Solutions Inc. boosted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 8.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,082 shares of the biotechnology company’s stock after acquiring an additional 81 shares during the period. Envestnet […] - 2025-03-27 09:14:51
Commonwealth Equity Services LLC increased its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 3.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,526 shares of the biotechnology company’s stock after buying an additional 301 shares during the quarter. […] - 2025-03-26 08:35:07
M&T Bank Corp increased its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 9.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,429 shares of the biotechnology company’s stock after buying an additional 294 shares […] - 2025-03-11 09:34:53
IFP Advisors Inc lessened its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 18.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 855 shares of the biotechnology company’s stock after selling 194 shares during the period. […] - 2025-03-03 09:00:52
Global Retirement Partners LLC raised its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 38.0% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 596 shares of the biotechnology company’s stock after purchasing an additional 164 shares during the period. Global Retirement Partners LLC’s holdings in United Therapeutics were worth $210,000 as […] - 2025-02-26 09:54:53
Blue Trust Inc. lowered its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 18.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,149 shares of the biotechnology company’s stock after selling 256 shares during the quarter. Blue Trust Inc.’s […] - 2025-02-18 11:06:55
Chevy Chase Trust Holdings LLC reduced its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 1.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 22,726 shares of the biotechnology company’s stock after selling 323 shares during the period. […] - 2025-02-18 08:42:54
Bleakley Financial Group LLC increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 58.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,059 shares of the biotechnology company’s stock after purchasing an additional 389 shares during the […] - 2025-02-11 08:56:58
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $76.4 million dollar outflow -- that's a 1.2% decrease week over week ( - 2025-02-05 16:06:35
Blue Trust Inc. lifted its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 24.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,745 shares of the biotechnology company’s stock after buying an additional 340 shares during […] - 2025-01-31 08:51:09
UTHR institutional holdings
The following institutional investment holdings of UTHR have been identified
Date
ETF ISIN/Name
Num Shares
Book value
Fatal error: Uncaught mysqli_sql_exception: Column 'Currency_Code' in field list is ambiguous in /var/www/liquidata/show_aggregate_holdings.php:119
Stack trace:
#0 /var/www/liquidata/show_aggregate_holdings.php(119): mysqli->query()
#1 {main}
thrown in /var/www/liquidata/show_aggregate_holdings.php on line 119